Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Innolign Biomedical

2013 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
3 INVESTORS
Description

Owner and operator of a biotechnology company intended to assist in therapeutic tissue regeneration. The company's biotechnology services focus on utilizing its novel microfabrication technologies and expertise in tissue engineering to develop high throughput organ-on-chip assessment platforms, enabling pharmaceutical industry to design novel biomaterials as products for promoting therapeutic tissue regeneration.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 3160 Chestnut Street
  • Suite 200
  • Philadelphia, PA 19104
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Innolign Biomedical’s full profile, request a free trial.

Innolign Biomedical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator 01-Dec-2013 Completed Startup
1. Grant 01-Jan-2013 $385K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Innolign Biomedical Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
UPstart Accelerator/Incubator Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Massachusetts Biomedical Initiatives Accelerator/Incubator 000 0000 000000 0

Innolign Biomedical Executive Team (2)

Name Title Board
Seat
Contact
Info
Melinda Shockley Ph.D Co-Founder & President
Christopher Chen Ph.D Co-Founder